First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes
- 1 February 2001
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 138 (2) , 244-249
- https://doi.org/10.1067/mpd.2001.111274
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.Diabetes, 1998
- Linear Loss of Insulin Secretory Capacity During the Last Six Months Preceding IDDM: No effect of antiedematous therapy with ketotifenDiabetes Care, 1994
- First-phase insulin release in normal childrenThe Journal of Pediatrics, 1993
- Standardization of IVGTT to Predict IDDMDiabetes Care, 1992
- Relationship Between First-Phase Insulin Secretion and Age, HLA, Islet Cell Antibody Status, and Development of Type I Diabetes in 220 Juvenile First-Degree Relatives of Diabetic PatientsDiabetes Care, 1991
- Prediction of the course of pre-type I diabetesThe Journal of Pediatrics, 1991
- Quantification of islet-cell antibodies and prediction of insulin-dependent diabetesThe Lancet, 1990
- The pattern of basal and stimulated insulin responses to intravenous glucose in first degree relatives of Type 1 (insulin-dependent) diabetic children and unrelated adults aged 5 to 50 yearsDiabetologia, 1988
- Diagnosis of pre-type I diabetesThe Journal of Pediatrics, 1987
- Pre-Type I Diabetes: Linear Loss of Beta Cell Response to Intravenous GlucoseDiabetes, 1984